GILEAD SCIENCES SL
- Country
- ๐ช๐ธSpain
- Ownership
- -
- Established
- 1994-01-01
- Employees
- -
- Market Cap
- $95.8B
A Phase II, Stratified, Randomized, Double-Blind, Multi-Center Study of the Safety and Efficacy of Adefovir Dipivoxil (ADF) at Two Dose Levels in Triple Combination Therapies With Protease Inhibitors (PI) and Nucleoside Reverse Transcriptase Inhibitors (RTI) for the Treatment of HIV-Infected Patient
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 120
- Registration Number
- NCT00002184
- Locations
- ๐บ๐ธ
Krauss Med Partners / Dept of Research and Development, Los Angeles, California, United States
๐บ๐ธUCLA Care Ctr, Los Angeles, California, United States
๐ต๐ทHosp Regional de Ponce - Area Vieja, Ponce, Puerto Rico
Safety and Effectiveness of Giving Adefovir Dipivoxil Plus Abacavir Plus Efavirenz Plus Amprenavir to HIV-Infected Patients Who Have Failed to Respond to Previous Protease Inhibitor Treatment
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 25
- Registration Number
- NCT00002419
- Locations
- ๐บ๐ธ
Brown Univ School of Medicine, Providence, Rhode Island, United States
๐บ๐ธAIDS Research Consortium of Atlanta, Atlanta, Georgia, United States
๐บ๐ธPacific Oaks Med Group, Beverly Hills, California, United States
The Safety of Tenofovir Disoproxil Fumarate Taken With Other Anti-HIV Drugs to Treat HIV-Infected Patients
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Gilead Sciences
- Registration Number
- NCT00007436
- Locations
- ๐บ๐ธ
Northstar Med Clinic, Chicago, Illinois, United States
๐บ๐ธAnderson Clinical Research, Pittsburgh, Pennsylvania, United States
๐บ๐ธPhysicans Home Service, Washington, District of Columbia, United States
The Safety and Effectiveness of Bis-POM PMEA in HIV-Infected Patients
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 36
- Registration Number
- NCT00002346
- Locations
- ๐บ๐ธ
Johns Hopkins Univ, Baltimore, Maryland, United States
Safety and Effectiveness of Tenofovir Disoproxil Fumarate (Tenofovir DF) Plus Other Anti-HIV Drugs in HIV-Infected Patients
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 600
- Registration Number
- NCT00002450
- Locations
- ๐บ๐ธ
Tower Infectious Diseases / Med Associates Inc, Los Angeles, California, United States
๐บ๐ธRemington Davis Inc, Columbus, Ohio, United States
๐บ๐ธThomas Street Clinic, Houston, Texas, United States
The Safety and Effectiveness of Adefovir Dipivoxil Plus Indinavir Combined With Zidovudine or Lamivudine or Stavudine in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 100
- Registration Number
- NCT00002379
- Locations
- ๐บ๐ธ
Phoenix Body Positive, Phoenix, Arizona, United States
๐บ๐ธSaint Vincent's AIDS Ctr, New York, New York, United States
๐บ๐ธGeorge Washington Med Ctr, Washington, District of Columbia, United States
An Open-Label Study of the Safety and Efficacy of Cidofovir for the Treatment of Relapsing Cytomegalovirus Retinitis in Patients With AIDS
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 100
- Registration Number
- NCT00002142
- Locations
- ๐บ๐ธ
Besselaar Associates, Princeton, New Jersey, United States
Safety and Effectiveness of Adding Adefovir Dipivoxil and Nelfinavir to the Anti-HIV Therapy of HIV-Infected Children
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 36
- Registration Number
- NCT00002219
- Locations
- ๐บ๐ธ
Bronx Lebanon Hosp Ctr / Dept of Pediatrics, Bronx, New York, United States
๐บ๐ธSt Lukes Roosevelt Hosp Ctr, New York, New York, United States
๐บ๐ธTulane Univ Med Ctr / Dept of Pediatrics, New Orleans, Louisiana, United States
The Safety and Effectiveness of Cidofovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 48
- Registration Number
- NCT00002437
- Locations
- ๐ฌ๐ง
Charing Cross and Westminster Med School, London SW 10, United Kingdom
๐บ๐ธMount Zion Med Ctr, San Francisco, California, United States
๐บ๐ธUniv of North Carolina Hosps, Chapel Hill, North Carolina, United States
A Study of Cidofovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Gilead Sciences
- Registration Number
- NCT00002384